Browse by Administration Route
This page shows data for Intravenous virus.
Total
Entries Retrieved: 4
| ID | Vaccine Name | Disease Name | Disease Classification | Virus Name | Nucleic Acid Content | Vaccine Type | Vaccine Status | Manufacturer | Year of Manufacturing | Manufacturing Country | Age | Dosage | Administration Route | Adjuvant | Target Strain | Description | Approving Organisation | Collaborating Organisation | Other Countries | Trade Name | PMID | Clinical Trial ID | Reference Link | Additional Links |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 10207 | AVI-6003 | Marburg hemorrhagic fever | Hemorrhagic | Marburg virus | negative-sense, single-stranded RNA | NA | Phase 1 | Sarepta Therapeutics Inc. | 2012 | USA | 18 - 55 years | NA | Intravenous | NA | NA | NA | NA | NA | NA | NA | NA | NCT01353040 | https://clinicaltrials.gov/ct2/show/NCT01353040?cond=Marburg+hemorrhagic+fever&draw=2&rank=1 | NA |
| 10221 | CHKV-24 | Chikungunya fever | Exanthous | Chikungunya virus | positive-sense, single-stranded RNA | RNA based vaccine | Phase 1 | NA | NA | NA | NA | Single dose | Intravenous | NA | NA | NA | NA | NA | NA | NA | 31921059 | NA | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6930866/ | NA |